Publications 2016

publication

“Two Time Point MS Lesion Segmentation in Brain MRI: An Expectation-Maximization Framework.” S Jain, A Ribbens, DM Sima, M Cambron, J De Keyser, C Wang, MH Barnett, S Van Huffel, F Maes, D Smeets. Frontiers in Neuroscience DOI: 10.3389/fnins.2016.00576 (2016).

“Migraine With Aura and Risk of Silent Brain Infarcts and White Matter Hyperintensities: an
MRI Study.” D Gaist, E Garde, M Blaabjerg, HH Nielsen, T Krøigard, K Østergaard, HS Møller, J Hjelmborg, CG Madsen, P Iversen, KO Kyvik, HR Siebner, M Ashina. Brain 139: 2015–2023 (2016).

“Nanodiamond–Gadolinium(III) Aggregates for Tracking Cancer Growth In Vivo at High Field.” N Rammohan, KW MacRenaris, LK Moore, G Parigi, DJ Mastarone, LM Manus, LM Lilley, AT Preslar, EA Waters, A Filicko, C Luchinat, D Ho, TJ Meade. Nano Letters DOI: 10.1021/acs.nanolett.6b03378 (2016).

“Fully Automated Segmentation of the Cervical Cord from T1-weighted MRI using PropSeg: Application to Multiple Sclerosis.” MC Yiannakas, AM Mustafa, B De Leener, H Kearney, C Tur, DR Altmann, F De Angelis, D Plantone, O Ciccarelli, DH Miller, J Cohen-Adad, CAM Gandini Wheeler-Kingshott. NeuroImage: Clinical 10:71-77 (2016).

“Fully Automated Grey and White Matter Spinal Cord Segmentation.” F Prados, MJ Cardoso, MC Yiannakas, LR Hoy, E Tebaldi, H Kearney, MD Liechti, DH Miller, O Ciccarelli, CAM Gandini Wheeler-Kingshott, S. Ourselin. Nature Scientific Reports DOI: 10.1038/srep36151 (2016).

“The Relevance of Cortical Lesions in Patients with Multiple Sclerosis.” O Geisseler, T Pflugshaupt, L Bezzola, K Reuter, D Weller, B Schuknecht, P Brugger, M Linnebank. BMC Neurology DOI: 10.1186/s12883-016-0718-9 (2016).

“Hippocampal and Deep Gray Matter Nuclei Atrophy is Relevant for Explaining Cognitive Impairment in MS:a Multicenter Study.” D Damjanovic, P Valsasina, MA Rocca, ML Stromillo, A Gallo, C Enzinger, HE Hulst, A Rovira, N Muhlert, N De Stefano, A Bisecco, F Fazekas, MJ Arévalo, TA Yousry, M Filippi. AJNR Am J Neuroradiol. DOI: 10.3174/ajnr.A4952 (2016).

“Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T.” MC Yiannakas , F Grussu, P Louka, F Prados, RS Samson, M Battiston, DR Altmann, S Ourselin, DH Miller, CAM Gandini Wheeler-Kingshott. PLoS One DOI: 10.1371/journal.pone.0164890 (2016).

“The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.” SL Dupuy, S Tauhid, S Hurwitz, R Chu, F Yousuf, R Bakshi. Neurol Ther. DOI: 10.1007/s40120-016-0054-4 (2016).

“Dissociation Between Iron Accumulation and Ferritin Upregulation in the Aged Substantia Nigra: Attenuation by Dietary Restriction.” T Walker, C Michaelides, A Ekonomou, K Geraki, HG Parkes, M Suessmilch, AH Herlihy, WR Crum, PW So. Aging (Albany NY) DOI: 10.18632/aging.101069 (2016).

“The Effect of Intramuscular Interferon Beta-1a on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.” SL Dupuy, F Khalid, BC Healy, S Bakshi, M Neema, S Tauhid, Rohit Bakshi. BMC Medical Imaging DOI: 10.1186/s12880-016-0158-4 (2016).

“Relationship of Grey and White Matter Abnormalities with Distance from the Surface of the Brain in Multiple Sclerosis.” M Pardini, CH Sudre, F Prados, O Yaldizli, V Sethi, N Muhlert, RS Samson, SH van de Pavert, MJ Cardoso, S Ourselin, CAM Gandini Wheeler-Kingshott, DH Miller, DT Chard. JNNP DOI: 10.1093/brain/awv065 (2016).

“Neurofilament Light Chain Level is a Weak Risk Factor for the Development of MS.” G Arrambide, C Espejo, H Eixarch, LM Villar, JC Alvarez-Cermeño, C Picón, J Kuhle, G Disanto, L Kappos, J Sastre-Garriga, D Pareto, E Simon, M Comabella, J Río, C Nos, C Tur, J Castilló, A Vidal-Jordana, I Galán, MJ Arévalo, C Auger, A Rovira, X Montalban, M Tintore. Neurology (2016).

“Patterns of White Matter Damage are Non-Random and Associated with Cognitive Function in Secondary Progressive Multiple Sclerosis.” KA Meijer, M Cercignani, N Muhlert, V Sethi, D Chard, JJG Geurts, O Ciccarelli. NeuroImage doi:10.1016/j.nicl.2016.06.009 (2016).

“The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.” F Yousuf, G Kim, S Tauhid, BI Glanz, R Chu, S Tummala, BC Healy, R Bakshi. Front. Neurol. 7:99 DOI: 10.3389/fneur.2016.00099 (2016).

“A Longitudinal Uncontrolled Study of Cerebral Gray Matter Volume in Patients Receiving Natalizumab for Multiple Sclerosis.” F Khalid, S Tauhid, AS Chua, BC Healy, JM Stankiewicz, HL Weiner, R Bakshi. International Journal of Neuroscience DOI: 10.1080/00207454.2016.1185421 (2016).

“Inhibition of FGF/FGFR Autocrine Signaling in Mesothelioma with the FGF Ligand Trap, FP-1039/GSK3052230.” C Blackwell, C Sherk, M Fricko, G Ganji, M Barnette, B Hoang, J Tunstead, T Skedzielewski, H Alsaid, BM Jucker, E Minthorn, R Kumar, MP DeYoung. Oncotarget DOI: 10.18632/oncotarget.9515 (2016).

“Strategic Lesions in the Anterior Thalamic Radiation and Apathy in Early Alzheimer’s Disease.” M Torso, L Serra, G Giulietti, B Spanò, E Tuzzi, G Koch, C Caltagirone, M Cercignani, M Bozzali. PLoS One (2016).

“Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases.” SB White, D Procissi, J Chen, VR Gogineni, P Tyler, Y Yang, RA Omary, AC Larson. PLoS One (2016).

“ZOOM or Non-ZOOM? Assessing Spinal Cord Diffusion Tensor Imaging Protocols for Multi-Centre Studies.” RS Samson , S Lévy, T Schneider, AK Smith, SA Smith, J Cohen-Adad, CAM Gandini Wheeler-Kingshott. PLoS One (2016).

“Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.” CB Beggs , C Magnano, P Belov, J Krawiecki, DP Ramasamy, J Hagemeier, R Zivadinov. PLoS One (2016).

“Quantitative MRI of the Spinal Cord and Brain in Adrenomyeloneuropathy: In Vivo Assessment of Structural Changes.” A Castellano, N Papinutto, M Cadioli, G Brugnara, A Iadanza, G Scigliuolo, D Pareyson, G Uziel, W Köhler, P Aubourg, A Falini, RG Henry, LS Politi, E Salsano. Brain (2016).

“Differing Patterns of Altered Slow-5 Oscillations in Healthy Aging and Ischemic Stroke.” C La, P Mossahebi, VA Nair, BM Young, J Stamm, R Birn, ME Meyerand, V Prabhakaran. Frontiers in Human Neuroscience http://dx.doi.org/10.3389/fnhum.2016.00156 (2016).

“Automated Brain Volumetrics in Multiple Sclerosis: a Step Closer to Clinical Application.” C Wang, HN Beadnall, SN Hatton, G Bader, D Tomic, DG Silva, MH Barnett. JNNP DOI: 10.1136/jnnp-2015-312304 (2016).

“Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas.” RJ Holbrook, N Rammohan, MW Rotz, KW MacRenaris, AT Preslar, TJ Meade. Nano Letters DOI: 10.1021/acs.nanolett.6b00599 (2016).

“Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.” MA Horsfield, MA Rocca, E Pagani, L Storelli, P Preziosa, R Messina, F Camesasca, M Copetti, M Filippi. Journal of Neuroimaging DOI: 10.1111/jon.12344 (2016).

“Recovery of Slow-5 Oscillations in a Longitudinal Study of Ischemic Stroke Patients.” C La, VA Nair, P Mossahebi, J Stamm, R Birn, ME Meyerand, V Prabhakaran. NeuroImage: Clinical DOI:10.1016/j.nicl.2016.03.008 (2016).

“Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.” A Harel, A Ceccarelli, C Farrell, M Fabian, J Howard, C Riley, A Miller, F Lublin, M Inglese. PLoS One DOI: 10.1371/journal.pone.0152180 (2016).

“The Cumulative Effect of Genetic Polymorphisms on Depression and Brain Structural Integrity.” M Kostic, Elisa Canu, F Agosta, A Munjiza, Ivana Novakovic, V Dobricic, PM Ferraro, VM Jerkovic, T Pekmezovic, DL Tosevski1, M Filippi. Human Brain Mapping DOI: 10.1002/hbm.23165 (2016).

“Serum Lipid Antibodies are Associated with Cerebral Tissue Damage in Multiple Sclerosis.” R Bakshi, A Yeste, B Patel, S Tauhid, S Tummala, R Rahbari, R Chu, K Regev, P Kivisäkk, HL Weiner, FJ Quintana. Neurol Neuroimmunol Neuroinflamm. 27:e200 (2016).

“Age-Related Brain Atrophy may be Mitigated by Internal Jugular Vein Enlargement in Male Individuals Without Neurologic Disease.” P Belov, Magnano, J Krawiecki, J Hagemeier, N Bergsland, C Beggs, R Zivadinov. Phlebology (2016).

“Fludarabine Add-On Therapy in Interferonbeta-Treated Patients with Multiple Sclerosis Experiencing Breakthrough Disease.” SJ Greenberg, R Zivadinov, P Lee-Kwen, J Sharma, M Planter, M Umhauer, N Glenister, R Bakshi. Therapeutic Advances in Neurological Disorders 1-13 (2016).

“Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals.” C Magnano, P Belov, J Krawiecki, J Hagemeier, C Beggs, R Zivadinov. PLoS One DOI: 10.1371/journal.pone.0149532 (2016).

“White Matter Lesions, Carotid and Coronary Atherosclerosis in Late-Onset Depression and Healthy Controls.” TA Devantier, BL Nørgaard, MK Poulsen, E Garde, KA Øvrehus, M Marwan, S Achenbach, D Dey, LH Sørensen, P Videbech. Psychosomatics (2016).

“Brain Structural Changes in Spasmodic Dysphonia: A Multimodal Magnetic Resonance Imaging Study.” VS Kostic, F Agosta, L Sarro, A Tomić, N Kresojević, S Galantucci, M Svetel, P Valsasina, M Filippi. Parkinsonism & Related Disorders (2016).

“Serum Lipid Antibodies are Associated with Cerebral Tissue Damage in Multiple Sclerosis.” R Bakshi, A Yeste, B Patel, S Tauhid, S Tummala, R Rahbari, R Chu, K Regev, P Kivisäkk, HL Weiner, FJ Quintana. Neurology 3: e200 (2016).

“Structural MRI Correlates of Cognitive Impairment in Patients with Multiple Sclerosis.” P Preziosa, MA Rocca, E Pagani, ML Stromillo, C Enzinger, A Gallo, HE Hulst, M Atzori, D Pareto, GC Riccitelli, M Copetti, N De Stefano, F Fazekas, A Bisecco, F Barkhof, TA Yousry, MJ Arévalo, M Filippi. Human Brain Mapping DOI: 10.1002/hbm.23125 (2016).

“Brain Intra- and Extracellular Sodium Concentration in Multiple Sclerosis: a 7 T MRI Study.” Petracca M, Vancea RO, Fleysher L, Jonkman LE, Oesingmann N, Inglese M. Brain (2016).

“A Semi-Automated Measuring System of Brain Diffusion and Perfusion Magnetic Resonance Imaging Abnormalities in Patients with Multiple Sclerosis Based on the Integration of Coregistration and Tissue Segmentation Procedures.” Revenaz A, Ruggeri M, Laganà M, Bergsland N, Groppo E, Rovaris M, Fainardi E. BMC Medical Imaging DOI: 10.1186/s12880-016-0108-1 (2016).

“An MRI-Defined Measure of Cerebral Lesion Severity to Assess Therapeutic Effects in Multiple Sclerosis.” Kim G, Tauhid S, Dupuy SL, Tummala S, Khalid F, Healy BC, Bakshi R. J Neurol. DOI: 10.1007/s00415-015-8009-8 (2016).

“High Fat Diet-Induced Diabetes in Mice Exacerbates Cognitive Deficit Due to Chronic Hypoperfusion.” Zuloaga KL, Johnson LA, Roese NE, Marzulla T, Zhang W, Nie X, Alkayed FN, Hong C, Grafe MR, Pike MM, Raber J, Alkayed NJ. Journal of Cerebral Blood Flow and Metabolism (2016).